NCT02561663View on ClinicalTrials.gov

NWT03 and Arterial Stiffness

NACompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Metabolic Syndrome
Interventions
DIETARY_SUPPLEMENT

NWT-03, an egg-white protein hydrolysate

egg-white protein hydrolysate

OTHER

Placebo

Trial Locations (1)

6229ER

Maastricht University Medical Centre+, Maastricht

All Listed Sponsors
collaborator

Maastricht University

OTHER

lead

Newtricious R&D BV

INDUSTRY

NCT02561663 - NWT03 and Arterial Stiffness | Biotech Hunter | Biotech Hunter